Answers are grounded in this paper and cite their sources.
Fetal DNA is present in plasma of pregnant women in amounts almost 1000-fold higher than the DNA present in intact fetal cells circulating in maternal peripheral blood (1)(2). The clinical usefulness of fetal DNA from plasma for noninvasive prenatal diagnosis has been demonstrated recently through analysis of the fetal RhD status by PCR-based approaches (3)(4)(5). We explored the possibility that not all of this fetal DNA is soluble and cell-free, but that part of it is still cell-associated. Heparin blood samples of 25–30 mL were obtained after informed consent from 38 pregnant women attending the Prenatal Diagnostic Center at week 7–16 of gestation. Several weeks after blood withdrawal, chorionic villus sampling or amniocentesis was performed as planned at each patient’s first visit. The protocol was approved by the Committee of Medical Ethics of the University Hospital ‘Vrije Universiteit’. Blood samples were processed on the day of withdrawal and were centrifuged on a discontinuous Percoll gradient as described previously (6)(7). In brief, after dilution of the heparin blood in Hanks’ balanced salt solution; 1:2 dilution (Life Technologies), blood was layered on a 5-step Percoll density gradient consisting of 15 mL of 600 mL/L and 5 mL each of 550, 500, 450, and 400 mL/L Percoll in Hanks’ balanced salt solution. After centrifugation for 25 min at 1000g at room temperature, plasma samples were removed from the upper part of the gradient, and cells with density 1.053–1.060 kg/L were removed for our study on circulating fetal trophoblast cells (7). The plasma samples were centrifuged twice for 10 min at 500g in a microcentrifuge, and pellets were washed in phosphate-buffered saline. After the cells were stained with 4′,6-diamidine-2′-phenylindole dihydrochloride, we noticed the presence of intact nuclei by microscopic analysis of these samples (300–400 cells/mL blood). Interestingly, the majority of these nuclei showed morphological features suggestive of apoptosis (a lobular appearance). When we used the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay (TUNEL) with the In Situ Cell Death Detection Kit (Roche Diagnostics), the majority of these cells (>95%) were labeled. In contrast, in control TUNEL assays using samples consisting of cells removed from the same gradient with density 1.053–1.060 kg/L, <1% of the cells were found to be in apoptosis. Cells isolated from plasma were pretreated by proteinase K incubation (final concentration, 0.5 g/L) for 60 min at 55 °C in PCR buffer and subjected to a nested X/Y-chromosome-specific PCR assay followed by Southern blotting to assess the presence of fetal DNA. The PCR was performed as described previously (6). All samples were positive for the X chromosome, indicating efficient isolation of DNA in all samples. The Y-chromosome-specific 254-bp end-product of the PCR assay was labeled with digoxigenin 11-dUTP and used as a probe for Southern blotting. Results of PCRs followed by blotting (Table 1 ) were compared with results of conventional karyotyping after chorionic villus sampling or amniocentesis in the same women (gold standard). PCR results of cells isolated from plasma of 31 pregnant women of 38 patients in total correlated with the gold standard (i.e., 81.6% correct). In two patients, PCR results were not interpretable. Three of 16 female samples were false positives, presumably because of contamination; at least one of these samples was negative in a subsequent assay. Two of 22 male samples were false negatives, probably because of the low amount of fetal DNA present in these very early pregnancy samples (all false-negative samples were obtained before 11 weeks of gestation). Lo et al. (3) described their RhD-PCR test as reliable at the beginning of the second trimester. When only samples taken at >11 weeks of gestation were included in our study (n = 10 male fetuses), no false-negative results were observed. Finally, using fluorescent DNA in situ hybridization (FISH) with directly labeled X- and Y-chromosome-specific probes (CEPX-SA, CEPY-SATIII-SO; Vysis, Downers Grove, IL), we found X/Y-positive cells, i.e., fetal cells, on microscope slides made from samples obtained identically from pregnant women carrying a male fetus. Cells isolated from plasma were layered on Superfrost Plus microscope slides (Mentzel-Gläser), air dried, fixed in acetone for 10 min, and stored at −20 °C. Before FISH, slides were rehydrated, postfixed in 10 g/L paraformaldehyde in phosphate-buffered saline (pH 7.0) for 10 min at room temperature, washed in phosphate-buffered saline, and dehydrated. The probe mixture, containing 1 μL of each probe, 1 μL of H2O, and 7 μL of CEP hybridization buffer (Vysis), and the target were co-denatured on a hot plate at 75 °C for 2.5 min. Hybridizations were performed overnight in a moist chamber at 42 °C. Slides were washed three times in 2× standard saline citrate (SSC) containing 500 mL/L formamide (pH 7–8) and once in 2× SSC (pH 7–7.5) for 10 min each at 45 °C and once in 2× SSC containing 1 g/L NP-40 for 5 min at 45 °C. Following dehydration, cells were embedded in Vectashield (Vector), and photographs were made using a Fuji film Sensia II 400 on a Zeiss Axiophot microscope equipped with filters for fluorescence and a 100 W mercury arc lamp. In a pilot experiment, samples from nine pregnant women (gestational age, 7–13 weeks) were analyzed using this X/Y-FISH assay: one false-positive and no false-negative results were obtained (88% correct). A representative FISH result is shown in Fig. 1 . In five samples from women with male fetuses, X/Y cells were found in all slides, varying from 1 to 5 cells per slide (∼2000 cells per slide). In four samples from women with female fetuses, in only one sample, one single positive X/Y cell was found. The relative proportion of apoptotic fetal and maternal cells isolated from plasma were between 1:500 and 1:2000. These data indicate that part of the fetal DNA present in plasma of pregnant women circulates in the form of intact cells and can easily be obtained by centrifugation of the plasma samples. Moreover, despite being in the process of apoptosis, these cells are amenable to both FISH and PCR analysis (at least X- and Y-chromosome identification). If confirmed for other chromosomes, this approach will allow not only rapid noninvasive analysis of fetal DNA by PCR, but also cytogenetic diagnosis of fetal chromosomal aneuploidies by FISH. Results of PCR analysis of cells isolated from plasma of pregnant women, compared with the gold standard (karyotype obtained following chorionic villus sampling or amniocentesis). *, PCR result not interpretable (smear on blot), leading to a noninformative sample. +, positive correlation; −, no correlation. Results of PCR analysis of cells isolated from plasma of pregnant women, compared with the gold standard (karyotype obtained following chorionic villus sampling or amniocentesis). *, PCR result not interpretable (smear on blot), leading to a noninformative sample. +, positive correlation; −, no correlation. FISH analysis of three cells, two maternal and one fetal, isolated from plasma of a woman carrying a male fetus. X-chromosome-specific signals are visible as blue dots with the aqua filter (A), and Y-chromosome-specific signals are visible as orange/green dots with the orange filter (B). This study was supported in part by the Dutch ‘Praeventiefonds/ZON′ (Grant 28-3022). We thank Drs. A.W.M. Nieuwint, Y.M. Heins, and K. Madan from the Department of Clinical Genetics and the physicians of the Division of Prenatal Diagnosis of the Department of Obstetrics and Gynecology for their support. We thank Vysis Inc. for their collaboration and for providing the chromosome-specific probes used in this work.
No takes yet. Share an insight, caveat, or question.
Wijk et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: